In a series of four patients with relapsed or refractory PCNSL, and one patient with CNS relapse of primary testicular lymphoma (PTL), all patients responded to treatment with the PD-1 inhibitor nivolumab. The gene discussed is PDCD1; the disease is primary central nervous system lymphoma.